Movement Alert｜CVS Health Falls 3.08% in Pre-Market Trading, Store Expansion Fails to Offset 340B Earnings Worries

Market Focus

Oct 09

On October 9, CVS Health fell 3.08% in pre-market trading, trading at $85.29 per share, with turnover of $556,000.

The positive news of the company opening its first pharmacy-focused store in Boston failed to support the stock, as market attention shifted to earnings pressure from the 340B drug discount program. BofA Securities maintained a Buy rating but lowered its price target from $120 to $110, pointing to greater earnings risk in 2027. The proposed changes to 340B reimbursement rules could create an EBIT headwind of $600 million to $700 million in 2027. While the company can offset these headwinds through Aetna margin recovery and other channels, short-term valuation pressure remains evident.

CVS Health Corporation provides health services in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, while its Retail/LTC segment operates approximately 9,900 retail locations and 1,200 MinuteClinic locations. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigermarketd.com/news/1108520552"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1108520552\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1108520552?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-09 19:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1108520552","market":"us","top_or_hot":-1,"title":"Movement Alert｜CVS Health Falls 3.08% in Pre-Market Trading, Store Expansion Fails to Offset 340B Earnings Worries","media":"Market Focus","content":"<p><p>On October 9, CVS Health fell 3.08% in pre-market trading, trading at $85.29 per share, with turnover of $556,000.</p><p>The positive news of the company opening its first pharmacy-focused store in Boston failed to support the stock, as market attention shifted to earnings pressure from the 340B drug discount program. BofA Securities maintained a Buy rating but lowered its price target from $120 to $110, pointing to greater earnings risk in 2027. The proposed changes to 340B reimbursement rules could create an EBIT headwind of $600 million to $700 million in 2027. While the company can offset these headwinds through Aetna margin recovery and other channels, short-term valuation pressure remains evident.</p><p>CVS Health Corporation provides health services in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, while its Retail/LTC segment operates approximately 9,900 retail locations and 1,200 MinuteClinic locations. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜CVS Health Falls 3.08% in Pre-Market Trading, Store Expansion Fails to Offset 340B Earnings Worries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜CVS Health Falls 3.08% in Pre-Market Trading, Store Expansion Fails to Offset 340B Earnings Worries\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-10-09 19:57</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On October 9, CVS Health fell 3.08% in pre-market trading, trading at $85.29 per share, with turnover of $556,000.</p><p>The positive news of the company opening its first pharmacy-focused store in Boston failed to support the stock, as market attention shifted to earnings pressure from the 340B drug discount program. BofA Securities maintained a Buy rating but lowered its price target from $120 to $110, pointing to greater earnings risk in 2027. The proposed changes to 340B reimbursement rules could create an EBIT headwind of $600 million to $700 million in 2027. While the company can offset these headwinds through Aetna margin recovery and other channels, short-term valuation pressure remains evident.</p><p>CVS Health Corporation provides health services in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, while its Retail/LTC segment operates approximately 9,900 retail locations and 1,200 MinuteClinic locations. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CVS","symbol_name":"西维斯健康","start_time":0,"source_url":"","article_id":"1108520552","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1108520552","pubTimestamp":1791547051,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On October 9, CVS Health fell 3.08% in pre-market trading, trading at $85.29 per share, with turnover of $556,000.The positive news of the company opening its first pharmacy-focused store in Boston...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CVS":"西维斯健康"},"translate_title":"走势警报|CVS Health 盘前交易下跌 3.08%，商店扩张未能抵消 340B 盈利担忧","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CVS":1},"content_text":"On October 9, CVS Health fell 3.08% in pre-market trading, trading at $85.29 per share, with turnover of $556,000.The positive news of the company opening its first pharmacy-focused store in Boston failed to support the stock, as market attention shifted to earnings pressure from the 340B drug discount program. BofA Securities maintained a Buy rating but lowered its price target from $120 to $110, pointing to greater earnings risk in 2027. The proposed changes to 340B reimbursement rules could create an EBIT headwind of $600 million to $700 million in 2027. While the company can offset these headwinds through Aetna margin recovery and other channels, short-term valuation pressure remains evident.CVS Health Corporation provides health services in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, while its Retail/LTC segment operates approximately 9,900 retail locations and 1,200 MinuteClinic locations. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}